<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05073874</url>
  </required_header>
  <id_info>
    <org_study_id>CHRO-2021-06</org_study_id>
    <nct_id>NCT05073874</nct_id>
  </id_info>
  <brief_title>Attentional Focus and Prefrontal Cortical Activation in Older Adults and Patients With Parkinson's Disease (PD)</brief_title>
  <acronym>AttPark</acronym>
  <official_title>Effects of Different Attentional Focus During Walking on Prefrontal Cortical Activation in Older Adults and Patients With Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Régional d'Orléans</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Régional d'Orléans</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Attention may influence the motor performance and frontal activity. This study will examine&#xD;
      the effect of different attentional focus: internal, external and divided attention (dual&#xD;
      task) on prefrontal cortical activation (fNIRS) and on gait performance. Thirty older adults&#xD;
      and thirty PD will participate in this study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The subjects will be guided to walk at a normal pace while maintaining the required&#xD;
      attentional focus. Subjects will walk on 20 m four times in each of the four different focus&#xD;
      conditions :&#xD;
&#xD;
        1. no instructions about the attentional focus&#xD;
&#xD;
        2. internal focus on their feet movements,&#xD;
&#xD;
        3. external focus on two lines drawn on the floor,&#xD;
&#xD;
        4. divided attention (walking while performing an arithmetic task).&#xD;
&#xD;
      A fNIRS system will be used for the prefrontal cortex activation evaluation and FeetMe soles&#xD;
      for gait analyses.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">May 2023</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effects of oxyhemoglobin variations on hemodynamic response in prefrontal cortex</measure>
    <time_frame>Baseline</time_frame>
    <description>Oxyhemoglobin variations in prefrontal cortex will be measured with a fNIRS system, on a 20 meters distance.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Effects of deoxyhemoglobin variations on hemodynamic response in prefrontal cortex</measure>
    <time_frame>Baseline</time_frame>
    <description>Deoxyhemoglobin variations in prefrontal cortex will be measured with a fNIRS system</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effects of speed on gait.</measure>
    <time_frame>baseline</time_frame>
    <description>Gait parameters will be measured with connected soles FeetMe ® : speed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects of cadence on gait.</measure>
    <time_frame>baseline</time_frame>
    <description>Gait parameters will be measured with connected soles FeetMe ® : cadence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects of stride length on gait.</measure>
    <time_frame>baseline</time_frame>
    <description>Gait parameters will be measured with connected soles FeetMe ® : stride length</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effects of double support time on gait.</measure>
    <time_frame>baseline</time_frame>
    <description>Gait parameters will be measured with connected soles FeetMe ® : double support time.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Functional Near-Infrared Spectroscopy (fNIRS)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects will be guided to walk at a normal pace while maintaining the required attentional focus:&#xD;
no instructions about the attentional focus&#xD;
internal focus on their feet movements,&#xD;
external focus on two lines drawn on the floor,&#xD;
divided attention (walking while performing an arithmetic task).&#xD;
A fNIRS system will be used for the prefrontal cortex activation evaluation and connected soles for gait analyses.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Functional Near-Infrared Spectroscopy (fNIRS)</intervention_name>
    <description>The hemodynamic response in prefrontal cortex will be measured using an Octomon+ system (Artinis). Eight emission and two detector probes will be arranged on the participant's forehead.</description>
    <arm_group_label>Functional Near-Infrared Spectroscopy (fNIRS)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  For 2 groups :&#xD;
&#xD;
               -  Man or woman 60-85 years old&#xD;
&#xD;
               -  Informed consent obtained&#xD;
&#xD;
          -  Group Parkinson : clinical diagnosis of idiopathic Parkinson's Disease, according to&#xD;
             the UK Brain Bank criteria.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  For 2 groups :&#xD;
&#xD;
               -  Assisted walker&#xD;
&#xD;
               -  Neurological (other than those resulting from Parkinson's disease), cardiologic,&#xD;
                  rheumatologic disorders&#xD;
&#xD;
               -  Disorders affecting gait.&#xD;
&#xD;
               -  Montreal Cognitive Assessment (MOCA) &lt; 24.&#xD;
&#xD;
               -  Concomitant medication likely to interfere with the results.&#xD;
&#xD;
          -  Group Parkinson:&#xD;
&#xD;
               -  freezing&#xD;
&#xD;
               -  Hoehn et Yahr &gt; III&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Canan OZSANCAK, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHR d'ORLEANS</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aurélie DESPUJOLS</last_name>
    <phone>+33238744071</phone>
    <email>aurelie.despujols@chr-orleans.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHR Orléans</name>
      <address>
        <city>Orléans</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Canan OZSANCAK, DR</last_name>
      <phone>+33 2 38 22 99 47</phone>
      <email>canan.ozsan@chr-orleans.fr</email>
    </contact>
    <investigator>
      <last_name>Canan OZSANCAK, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Baltadjieva R, Giladi N, Gruendlinger L, Peretz C, Hausdorff JM. Marked alterations in the gait timing and rhythmicity of patients with de novo Parkinson's disease. Eur J Neurosci. 2006 Sep;24(6):1815-20.</citation>
    <PMID>17004944</PMID>
  </reference>
  <reference>
    <citation>Hausdorff JM. Gait dynamics, fractals and falls: finding meaning in the stride-to-stride fluctuations of human walking. Hum Mov Sci. 2007 Aug;26(4):555-89. Epub 2007 Jul 5. Review.</citation>
    <PMID>17618701</PMID>
  </reference>
  <reference>
    <citation>Mahoney JR, Holtzer R, Izzetoglu M, Zemon V, Verghese J, Allali G. The role of prefrontal cortex during postural control in Parkinsonian syndromes a functional near-infrared spectroscopy study. Brain Res. 2016 Feb 15;1633:126-138. doi: 10.1016/j.brainres.2015.10.053. Epub 2015 Nov 6.</citation>
    <PMID>26551767</PMID>
  </reference>
  <reference>
    <citation>Plotnik M, Giladi N, Dagan Y, Hausdorff JM. Postural instability and fall risk in Parkinson's disease: impaired dual tasking, pacing, and bilateral coordination of gait during the &quot;ON&quot; medication state. Exp Brain Res. 2011 May;210(3-4):529-38. doi: 10.1007/s00221-011-2551-0. Epub 2011 Jan 30.</citation>
    <PMID>21279632</PMID>
  </reference>
  <reference>
    <citation>Yogev-Seligmann G, Rotem-Galili Y, Mirelman A, Dickstein R, Giladi N, Hausdorff JM. How does explicit prioritization alter walking during dual-task performance? Effects of age and sex on gait speed and variability. Phys Ther. 2010 Feb;90(2):177-86. doi: 10.2522/ptj.20090043. Epub 2009 Dec 18.</citation>
    <PMID>20023000</PMID>
  </reference>
  <reference>
    <citation>Pelicioni PHS, Tijsma M, Lord SR, Menant J. Prefrontal cortical activation measured by fNIRS during walking: effects of age, disease and secondary task. PeerJ. 2019 May 3;7:e6833. doi: 10.7717/peerj.6833. eCollection 2019.</citation>
    <PMID>31110922</PMID>
  </reference>
  <reference>
    <citation>Wulf G, Höß M, Prinz W. Instructions for motor learning: differential effects of internal versus external focus of attention. J Mot Behav. 1998 Jun;30(2):169-79. doi: 10.1080/00222899809601334.</citation>
    <PMID>20037032</PMID>
  </reference>
  <reference>
    <citation>Holtzer R, Verghese J, Allali G, Izzetoglu M, Wang C, Mahoney JR. Neurological Gait Abnormalities Moderate the Functional Brain Signature of the Posture First Hypothesis. Brain Topogr. 2016 Mar;29(2):334-43. doi: 10.1007/s10548-015-0465-z. Epub 2015 Nov 27.</citation>
    <PMID>26613725</PMID>
  </reference>
  <reference>
    <citation>Maidan I, Bernad-Elazari H, Giladi N, Hausdorff JM, Mirelman A. When is Higher Level Cognitive Control Needed for Locomotor Tasks Among Patients with Parkinson's Disease? Brain Topogr. 2017 Jul;30(4):531-538. doi: 10.1007/s10548-017-0564-0. Epub 2017 Apr 24.</citation>
    <PMID>28439757</PMID>
  </reference>
  <reference>
    <citation>Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord. 2008 Feb 15;23(3):329-42; quiz 472. Review.</citation>
    <PMID>18058946</PMID>
  </reference>
  <reference>
    <citation>Lu CF, Liu YC, Yang YR, Wu YT, Wang RY. Maintaining Gait Performance by Cortical Activation during Dual-Task Interference: A Functional Near-Infrared Spectroscopy Study. PLoS One. 2015 Jun 16;10(6):e0129390. doi: 10.1371/journal.pone.0129390. eCollection 2015.</citation>
    <PMID>26079605</PMID>
  </reference>
  <reference>
    <citation>Udina C, Avtzi S, Durduran T, Holtzer R, Rosso AL, Castellano-Tejedor C, Perez LM, Soto-Bagaria L, Inzitari M. Functional Near-Infrared Spectroscopy to Study Cerebral Hemodynamics in Older Adults During Cognitive and Motor Tasks: A Review. Front Aging Neurosci. 2020 Jan 21;11:367. doi: 10.3389/fnagi.2019.00367. eCollection 2019. Review.</citation>
    <PMID>32038224</PMID>
  </reference>
  <reference>
    <citation>Kal EC, van der Kamp J, Houdijk H. External attentional focus enhances movement automatization: a comprehensive test of the constrained action hypothesis. Hum Mov Sci. 2013 Aug;32(4):527-39. doi: 10.1016/j.humov.2013.04.001. Epub 2013 Jun 30.</citation>
    <PMID>24054892</PMID>
  </reference>
  <reference>
    <citation>Nieuwhof F, Reelick MF, Maidan I, Mirelman A, Hausdorff JM, Olde Rikkert MG, Bloem BR, Muthalib M, Claassen JA. Measuring prefrontal cortical activity during dual task walking in patients with Parkinson's disease: feasibility of using a new portable fNIRS device. Pilot Feasibility Stud. 2016 Sep 23;2:59. eCollection 2016.</citation>
    <PMID>27965875</PMID>
  </reference>
  <reference>
    <citation>Yogev-Seligmann G, Sprecher E, Kodesh E. The Effect of External and Internal Focus of Attention on Gait Variability in Older Adults. J Mot Behav. 2017 Mar-Apr;49(2):179-184. doi: 10.1080/00222895.2016.1169983. Epub 2016 Aug 11.</citation>
    <PMID>27715480</PMID>
  </reference>
  <reference>
    <citation>Holtzer R, Mahoney JR, Izzetoglu M, Izzetoglu K, Onaral B, Verghese J. fNIRS study of walking and walking while talking in young and old individuals. J Gerontol A Biol Sci Med Sci. 2011 Aug;66(8):879-87. doi: 10.1093/gerona/glr068. Epub 2011 May 17.</citation>
    <PMID>21593013</PMID>
  </reference>
  <reference>
    <citation>Farid L, Jacobs D, Do Santos J, Simon O, Gracies JM, Hutin E. FeetMe® Monitor-connected insoles are a valid and reliable alternative for the evaluation of gait speed after stroke. Top Stroke Rehabil. 2021 Mar;28(2):127-134. doi: 10.1080/10749357.2020.1792717. Epub 2020 Jul 13.</citation>
    <PMID>32654627</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 29, 2021</study_first_submitted>
  <study_first_submitted_qc>October 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 12, 2021</study_first_posted>
  <last_update_submitted>October 11, 2021</last_update_submitted>
  <last_update_submitted_qc>October 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Attention</keyword>
  <keyword>NIRS</keyword>
  <keyword>Gait</keyword>
  <keyword>Prefrontal cortex</keyword>
  <keyword>Parkinson's disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

